WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Seamus Taylor
Associate
Regulatory
Washington, D.C.
seamus.taylor@wsgr.com

D202-973-8961

Download vCard
Open PDF

Seamus Taylor is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm’s digital health industry group and its healthcare practice. Seamus helps clients ranging from start-ups to publicly traded companies navigate the complex world of health law.

Seamus regularly advises clients on corporate practice of medicine laws; state and federal fraud and abuse laws such as the Anti-Kickback Statute, the Stark Law, and the False Claims Act; HIPAA and privacy laws; Medicare and Medicaid rules; investigations; and state licensing requirements. He is a go-to advisor on transactions such as mergers, acquisitions, and financings, and on contractual arrangements such as professional service agreements and employment agreements.

Seamus also counsels clients on corporate and governance issues such as entity formation, preparing policies and procedures, and compliance programs.

Prior to attending law school, Seamus obtained his MPH at the University of Iowa College of Public Health, where he specialized in health policy and healthcare management.

Experience

Seamus Taylor is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm’s digital health industry group and its healthcare practice. Seamus helps clients ranging from start-ups to publicly traded companies navigate the complex world of health law.

Seamus regularly advises clients on corporate practice of medicine laws; state and federal fraud and abuse laws such as the Anti-Kickback Statute, the Stark Law, and the False Claims Act; HIPAA and privacy laws; Medicare and Medicaid rules; investigations; and state licensing requirements. He is a go-to advisor on transactions such as mergers, acquisitions, and financings, and on contractual arrangements such as professional service agreements and employment agreements.

Seamus also counsels clients on corporate and governance issues such as entity formation, preparing policies and procedures, and compliance programs.

Prior to attending law school, Seamus obtained his MPH at the University of Iowa College of Public Health, where he specialized in health policy and healthcare management.

Education
  • J.D., University of Iowa College of Law, 2022
  • M.P.H., Health Policy, University of Iowa College of Public Health, 2019
  • A.B., Vassar College, 2017
Associations and Memberships
  • Co-chair, Iowa State Bar Association Health Law Section
  • Vice Chair, American Bar Association Health Law Section Managed Care & Insurance Interest Group
Admissions
  • Bar of the District of Columbia
  • State Bar of Iowa
Credentials
Education
  • J.D., University of Iowa College of Law, 2022
  • M.P.H., Health Policy, University of Iowa College of Public Health, 2019
  • A.B., Vassar College, 2017
Associations and Memberships
  • Co-chair, Iowa State Bar Association Health Law Section
  • Vice Chair, American Bar Association Health Law Section Managed Care & Insurance Interest Group
Admissions
  • Bar of the District of Columbia
  • State Bar of Iowa

Select Publications

  • Co-author, "Offering Equity to Physicians in an MSO/PC Structure: Key Fraud and Abuse Compliance Considerations," Wilson Sonsini Client Advisory, August 19, 2025
  • Co-author, "CMS Announces Creation of Health Tech Ecosystem for Improving Access to Patient Data," Wilson Sonsini Alert, August 1, 2025
  • Co-author, "Oregon Enacts Nation’s Most Restrictive CPOM Law," Wilson Sonsini Alert, June 13, 2025
  • Co-author, "Telehealth Companies Sued for Selling Compounded GLP-1 Drugs and Violations of Corporate Practice of Medicine Laws," Wilson Sonsini Alert, May 5, 2025
  • Co-author, "The Corporate Practice of Medicine: Essential Guidance for Digital Health Companies and Investors," Wilson Sonsini Client Advisory, March 27, 2025
  • Co-author, "California AG Issues Legal Advisory Regarding Use of AI in Healthcare," Wilson Sonsini Alert, February 26, 2025
  • Co-author, "Key Considerations for Contracting with Healthcare Revenue Cycle Management Companies," Wilson Sonsini Alert, February 26, 2025
  • Co-author, "DEA Proposes Updates to Rules for Prescribing Controlled Substances That Could Significantly Impact Telemedicine Companies and Their Investors," Wilson Sonsini Alert, January 22, 2025
  • Co-author, "Medicare Telehealth Flexibilities Extended Through March 2025," Wilson Sonsini Alert, December 23, 2024
  • Co-author, "DEA and HHS Extend COVID-19 Telemedicine Prescribing Flexibilities Again," Wilson Sonsini Alert, November 20, 2024
  • Co-author, “Governor Newsom Signs (and Vetoes) Major California AI Legislation,” Wilson Sonsini Alert, October 10, 2024
  • Co-author, “California Governor Gavin Newsom Vetoes Law Requiring Attorney General Approval for Certain Healthcare Investments,” Wilson Sonsini Alert, October 4, 2024
  • Co-author with A. Prince, “Artificial intelligence: attempts at developing an ethical approach for its use in insurance,” Research Handbook on International Insurance Law and Regulation (2nd edition) 647–673, 2023
Insights

Select Publications

  • Co-author, "Offering Equity to Physicians in an MSO/PC Structure: Key Fraud and Abuse Compliance Considerations," Wilson Sonsini Client Advisory, August 19, 2025
  • Co-author, "CMS Announces Creation of Health Tech Ecosystem for Improving Access to Patient Data," Wilson Sonsini Alert, August 1, 2025
  • Co-author, "Oregon Enacts Nation’s Most Restrictive CPOM Law," Wilson Sonsini Alert, June 13, 2025
  • Co-author, "Telehealth Companies Sued for Selling Compounded GLP-1 Drugs and Violations of Corporate Practice of Medicine Laws," Wilson Sonsini Alert, May 5, 2025
  • Co-author, "The Corporate Practice of Medicine: Essential Guidance for Digital Health Companies and Investors," Wilson Sonsini Client Advisory, March 27, 2025
  • Co-author, "California AG Issues Legal Advisory Regarding Use of AI in Healthcare," Wilson Sonsini Alert, February 26, 2025
  • Co-author, "Key Considerations for Contracting with Healthcare Revenue Cycle Management Companies," Wilson Sonsini Alert, February 26, 2025
  • Co-author, "DEA Proposes Updates to Rules for Prescribing Controlled Substances That Could Significantly Impact Telemedicine Companies and Their Investors," Wilson Sonsini Alert, January 22, 2025
  • Co-author, "Medicare Telehealth Flexibilities Extended Through March 2025," Wilson Sonsini Alert, December 23, 2024
  • Co-author, "DEA and HHS Extend COVID-19 Telemedicine Prescribing Flexibilities Again," Wilson Sonsini Alert, November 20, 2024
  • Co-author, “Governor Newsom Signs (and Vetoes) Major California AI Legislation,” Wilson Sonsini Alert, October 10, 2024
  • Co-author, “California Governor Gavin Newsom Vetoes Law Requiring Attorney General Approval for Certain Healthcare Investments,” Wilson Sonsini Alert, October 4, 2024
  • Co-author with A. Prince, “Artificial intelligence: attempts at developing an ethical approach for its use in insurance,” Research Handbook on International Insurance Law and Regulation (2nd edition) 647–673, 2023
Focus Areas
  • AI in Healthcare
  • Corporate
  • Digital Health
  • FDA Regulatory, Healthcare, and Consumer Products
  • Life Sciences
  • Mergers & Acquisitions
  • Regulatory
Recent Insights
Alerts
California Attorney General Targets MSO-PC Structures: What the Art Center Holdings Amicus Brief Means for CPOM Compliance
Executive Summary
Learn More
Client Highlights
Firm Advises Getlabs on Acquisition by Function
On April 8, 2026, Function Health announced it has acquired Getlabs, a leading mobile healthcare platform that brings licensed specialists directly to one's location. The acquisition allows for the continuation of Getlab’s nationwide network of providers, health systems, and partners, while advancing Function's broader commitment to making healthcare more accessible by building experiences around member needs. Wilson Sonsini Goodrich & Rosati advised Getlabs on the transaction.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.